Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.

Hickey AJ, Hazlett KR, Kirimanjeswara GS, Metzger DW.

Vaccine. 2011 Sep 16;29(40):6941-7. doi: 10.1016/j.vaccine.2011.07.075. Epub 2011 Jul 29.

2.

Nature of protective immunity to Francisella tularensis.

Tärnvik A.

Rev Infect Dis. 1989 May-Jun;11(3):440-51. Review.

PMID:
2665002
3.

Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.

Elkins KL, Cowley SC, Bosio CM.

Microbes Infect. 2003 Feb;5(2):135-42. Review.

PMID:
12650771
4.

Vaccination strategies for Francisella tularensis.

Isherwood KE, Titball RW, Davies DH, Felgner PL, Morrow WJ.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1403-14. Review.

PMID:
15919131
5.

Virulence determinants and protective antigens of Francisella tularensis.

Sjöstedt A.

Curr Opin Microbiol. 2003 Feb;6(1):66-71. Review.

PMID:
12615222
6.

[Tularemia vaccine strain is a potential vector].

Pavlov VM, Mokrievich AN, Noskov AN, Urakov NN.

Vestn Ross Akad Med Nauk. 1997;(6):30-2. Review. Russian.

PMID:
9289276
7.

Live attenuated tularemia vaccines: recent developments and future goals.

Marohn ME, Barry EM.

Vaccine. 2013 Aug 2;31(35):3485-91. doi: 10.1016/j.vaccine.2013.05.096. Epub 2013 Jun 10. Review.

8.

Rationally designed tularemia vaccines.

Mann BJ, Ark NM.

Expert Rev Vaccines. 2009 Jul;8(7):877-85. doi: 10.1586/erv.09.51. Review.

9.

Vaccines against Francisella tularensis--past, present and future.

Conlan JW.

Expert Rev Vaccines. 2004 Jun;3(3):307-14. Review.

PMID:
15176947
10.

Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.

Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW.

Immunol Rev. 2008 Oct;225:244-55. doi: 10.1111/j.1600-065X.2008.00689.x. Review.

11.

Tularemia vaccines.

Putzova D, Senitkova I, Stulik J.

Folia Microbiol (Praha). 2016 Nov;61(6):495-504. Epub 2016 May 19. Review.

PMID:
27194547
12.

Immunotherapy for tularemia.

Skyberg JA.

Virulence. 2013 Nov 15;4(8):859-70. doi: 10.4161/viru.25454. Epub 2013 Jun 19. Review.

13.

Mucosal immunopathogenesis of Francisella tularensis.

Metzger DW, Bakshi CS, Kirimanjeswara G.

Ann N Y Acad Sci. 2007 Jun;1105:266-83. Epub 2007 Mar 29. Review.

PMID:
17395728
14.

Francisella Inflammasomes: Integrated Responses to a Cytosolic Stealth Bacterium.

Wallet P, Lagrange B, Henry T.

Curr Top Microbiol Immunol. 2016;397:229-56. doi: 10.1007/978-3-319-41171-2_12. Review.

PMID:
27460813
15.

Vaccines against tularemia.

Barry EM, Cole LE, Santiago AE.

Hum Vaccin. 2009 Dec;5(12):832-8. Epub 2009 Dec 11. Review.

16.

Tularemia.

Ellis J, Oyston PC, Green M, Titball RW.

Clin Microbiol Rev. 2002 Oct;15(4):631-46. Review.

17.

Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity.

Steiner DJ, Furuya Y, Metzger DW.

Infect Drug Resist. 2014 Sep 18;7:239-51. doi: 10.2147/IDR.S53700. eCollection 2014. Review.

18.

From the Outside-In: The Francisella tularensis Envelope and Virulence.

Rowe HM, Huntley JF.

Front Cell Infect Microbiol. 2015 Dec 23;5:94. doi: 10.3389/fcimb.2015.00094. eCollection 2015. Review.

19.

Multifaceted effects of Francisella tularensis on human neutrophil function and lifespan.

Kinkead LC, Allen LA.

Immunol Rev. 2016 Sep;273(1):266-81. doi: 10.1111/imr.12445. Review.

PMID:
27558340
20.

An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis.

Valentino M, Frelinger J.

Immunol Res. 2009 Dec;45(2-3):218-28. doi: 10.1007/s12026-009-8103-z. Epub 2009 Feb 11. Review.

Supplemental Content

Support Center